Castle Biosciences

CSTL

NASDAQHealth Care

Income Statement

Total Revenue$332.07M

Gross Profit$271.86M

Operating Income$8.67M

EBITDA$38.14M

EBIT$22.14M

Pre-tax Income$-17.66M

Net Income$18.25M

Cash Equivalent$95.8M

Total Debt$25.83M

Book Value$430.81M

Book Value Per Share15.55

Return on Equity (ROE)+4.00%

Return on Assets (ROA)+3.43%

Return on Invested Capital (ROI)+3.91%

Net Profit Margin+5.49%

Current Ratio7.29

Quick Ratio6.97

Long-Term Debt / Equity0.02